Pre-eclampsia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{Sara.Zand}} | {{CMG}} {{AE}} {{Sara.Zand}} | ||
== Overview == | == Overview == | ||
*Secondary prevention strategies following [[preeclampsia]] include the | *Secondary prevention strategies following [[preeclampsia]] include the following: | ||
:* [[Blood pressure]] monitoring | :* [[Blood pressure]] monitoring | ||
:* Repeated assessment of [[proteinuria]] if the result is negative | :* Repeated assessment of [[proteinuria]] if the result is negative | ||
:* Clinical evaluation about [[clonus]] | :* Clinical evaluation about [[clonus]] | ||
:* Measurement of [[blood test]] twice weekly for [[hemoglubin]],[[patelet count]], [[uric acid]] [[liver enzyme test]], [[renal function test]] | :* Measurement of [[blood test]] twice weekly for [[hemoglubin]],[[patelet count]], [[uric acid]] [[liver enzyme test]], [[renal function test]] | ||
==References== | ==References== | ||
Revision as of 17:16, 10 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia secondary prevention |
|
Risk calculators and risk factors for Pre-eclampsia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
- Secondary prevention strategies following preeclampsia include the following:
- Blood pressure monitoring
- Repeated assessment of proteinuria if the result is negative
- Clinical evaluation about clonus
- Measurement of blood test twice weekly for hemoglubin,patelet count, uric acid liver enzyme test, renal function test